SEC Form 4/A · accession 0001179110-18-005561
Tabula Rasa HealthCare, Inc. · TRHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Orsula V Knowlton
Officer — President · Director
Period of report
Mar 7, 2018
Accepted (ET)
Apr 10, 2018 · 6:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F4 | Mar 7, 2018 | S | 3,129 | $35.37 | D | 908,480 | I | Held by spouse. |
| Common StockF3,F5 | Mar 7, 2018 | S | 4,871 | $35.73 | D | 903,609 | I | Held by spouse. |
| Common StockF6 | holding | — | — | — | 887,641 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Calvin H. Knowlton on December 4, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $34.81 to $35.69, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $35.70 to $35.84, inclusive.
- F4Previous disclosure stated that the Amount of Securities Beneficially Owned Following Reported Transaction(s) in Column 5 was 829,443. Notwithstanding the foregoing, the Amount of Securities Beneficially Owned Following Reported Transaction(s) in Column 5 is 908,480.
- F5Previous disclosure stated that the Amount of Securities Beneficially Owned Following Reported Transaction(s) in Column 5 was 824,572. Notwithstanding the foregoing, the Amount of Securities Beneficially Owned Following Reported Transaction(s) in Column 5 is 903,609.
- F6Previous disclosure stated that the Amount of Securities Beneficially Owned Following Reported Transaction(s) in Column 5 was 821,907. Notwithstanding the foregoing, the Amount of Securities Beneficially Owned Following Reported Transaction(s) in Column 5 is 887,641.